USPTO serial 79029262
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Chemical preparations for use in industry, science and laboratories; biological preparations for use in industry, science and laboratories, namely, for use in research, analysis and diagnostics, namely,, bacteria for use in connection with the research of epitopes and antigenes as well-as for prophylaxis and therapy of medical conditions ] | SECTION 71 - CANCELLED | — |
| 005 | [ Pharmaceutical and veterinary preparations, namely, for treatment of infectious diseases, auto-immune diseases, dementia diseases, namely, Alzheimer's disease or arteriosclerotic diseases; vaccines; diagnostic preparations for medical purposes; chemical reagents for medical and veterinary purposes; chemical and biological preparations for medical use ] | SECTION 71 - CANCELLED | — |
| 010 | [ Surgical, medical, dental and veterinary instruments and apparatus as well as replacement parts of the aforementioned goods, namely, instruments and apparatus for use in therapy and prophylaxis of medical conditions, namely, for use in general surgery; medical apparatus and instruments, namely, for use in therapy and prophylaxis of medical conditions, namely, for treatment of infectious diseases, auto-immune diseases, dementia diseases, namely, Alzheimer's disease or arteriosclerotic diseases; apparatus for use in medical analysis, namely, for use in therapy and prophylaxis of medical conditions, namely, for blood analysis for clinical diagnosis ] | SECTION 71 - CANCELLED | — |
| 042 | Development or medical diagnostic, therapy and test methods, namely, conducting clinical trials, scientific investigations for medical purposes, research in the field of chemical medicine, pharmaceutics and bacteriology | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 5, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 11, 2022 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Nov 1, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 29, 2019 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 28, 2019 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 27, 2019 | INPC | INVALIDATION PROCESSED | — |
| Jul 2, 2019 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 2, 2018 | C71T | CANCELLED SECTION 71 | — |
| Apr 1, 2017 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Jun 30, 2016 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jun 20, 2015 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Apr 9, 2015 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Apr 9, 2015 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Oct 7, 2014 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 7, 2014 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Feb 7, 2014 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Feb 7, 2014 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 23, 2014 | 71AF | REGISTERED-SEC.71 FILED | — |
| Jan 23, 2014 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Dec 22, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 4, 2011 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 17, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 17, 2008 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 3, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 1, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 15, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 26, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 12, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 11, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 8, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 8, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 8, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 15, 2007 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 14, 2007 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 25, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jul 25, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 23, 2007 | PAPER RECEIVED | — | |
| Jun 22, 2007 | CPRA | PRIORITY ACTION MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jun 21, 2007 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| May 30, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 30, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 30, 2007 | ALIE | ASSIGNED TO LIE | — |
| May 29, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 11, 2007 | PAPER RECEIVED | — | |
| Dec 8, 2006 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 21, 2006 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 21, 2006 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 18, 2006 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 17, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 3, 2006 | NWAP | NEW APPLICATION ENTERED | — |
| Nov 2, 2006 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |